Skip to main content
Premium Trial:

Request an Annual Quote

Coimbra Genomics Supporting Portuguese Clinical Exome Sequencing Initiative

NEW YORK (GenomeWeb) – Digital health and precision medicine firm Coimbra Genomics today said it has joined the first initiative by a Portuguese hospital center to provide exome sequencing to its patients.

As part of its support of the initiative, Coimbra is adapting its platform for integration into the analysis of the exome data.

The initiative is part of the In2Genome project and aims to develop new methods for exome analysis and to report the results in a molecular diagnostic report. Coimbra Genomics' platform, Elsie, will be used for analysis of clinical cases at the medical genetics unit of Coimbra Hospital and Universitary Centre (CHUC), it said.

In2Genome is led by Coimbra, which is being funded with about €1.2 million ($1.4 million) by Portugal 2020, Compete 2020, and the European Structural and Investment Funds. The project will last from July 1, 2017 to June 30, 2019. The medical genetics unit at CHUC and Genoinseq are partners in In2Genome.

Elsie is digital platform that allows physicians to make diagnostic and prognostic decisions based on a patient's genome. 

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.